| 摘要 |
The present invention relates to a method for diagnosis of dementia by measuring the concentration of PGCP present in plasma. More specifically, it was determined that the plasma concentration of PGCP in patients with dementia was significantly higher than that of the normal population and the mild cognitive disorder group, and accordingly, a dementia diagnosis kit was developed using the PGCP protein as a diagnostic marker and the same was found to be very useful in a method for diagnosis of dementia. |
